-
Symbol
-
CTMX on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.00001 par value per share
-
Latest Disclosed Ownership
-
48.9K shares
-
Security Ownership
-
0.02%
Seven Fleet Master Fund LP ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)
2025-11-14 - Seven Fleet Master Fund LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 48.9K shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
This represents 0.02% percent ownership of the company.